$NVNO

$6.74 +$0.03 (0.45%) Close

$NVNO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$NVNO Management Team

Ms. Jennifer Bright

Chief Financial Officer

Age 54

Compensation -

Sex Female

Dr. Marc Glickman

Senior Vice President

Chief Medical Officer

Age 75

Compensation $626.6K USD

Sex Male

Dr. Hamed Alavi

Senior Vice President

Chief Technology Officer

Age 41

Compensation $521.9K USD

Sex Male

Mr. Robert Berman

Chief Executive Officer

Director

Age 62

Compensation $1.161M USD

Sex Male

Name / Title	Age	Compensation	Sex
Ms. Jennifer Bright Chief Financial Officer	54	-	Female
Dr. Marc Glickman Senior Vice President Chief Medical Officer	75	$626.6K USD	Male
Dr. Hamed Alavi Senior Vice President Chief Technology Officer	41	$521.9K USD	Male
Mr. Robert Berman Chief Executive Officer Director	62	$1.161M USD	Male

Board of Directors

From the proxy statement filed Oct 30, 2025

Directors

serving now

Independent

4 of 4

stated in the proxy; 1 not stated

Average tenure

6.6 years

from year joined

CEO also chairs the board

Not stated

no chair stated

Director	Age	On board	Independent	Committees	Other public boards	Pay
Robert A. Berman CEO	62	2018 7 years	Not stated	None stated	None stated	Paid as CEO
Dr. Francis Duhay	65	2018 7 years	Independent	None stated	None stated	Not stated
Dr. Sanjay Shrivastava	58	2018 7 years	Independent	None stated	None stated	Not stated
Matthew M. Jenusaitis	64	2019 6 years	Independent	None stated	None stated	Not stated
Robert C. Gray	78	2019 6 years	Independent	Audit Committee · Chair	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Oct 30, 2025

Perceptive Life Sciences Master Fund, Ltd.

a holder of greater than 5% of our Common Stock

Amount not stated

October 6, 2023

Participated as an investor in a financing by purchasing pre-funded warrants and Tranche A and Tranche B warrants to purchase Common Stock under a purchase agreement.

With the Company Open in proxy

Comments

Company Executives

$NVNO Management Team

Ms. Jennifer Bright

Dr. Marc Glickman

Dr. Hamed Alavi

Mr. Robert Berman

Board of Directors

Related-party transactions